ERRATUM TO: VIABILITY OF EQUINE MESENCHYMAL STEM CELLS DURING TRANSPORT AND IMPLANTATION by Garvican, E R et al.
ERRATUM Open Access
Erratum to: Viability of equine
mesenchymal stem cells during transport
and implantation
Elaine R. Garvican, Sandra Cree†, Lydia Bull†, Roger K. W. Smith and Jayesh Dudhia*
Erratum
Following the publication of our article [1] the following
minor errors and omissions were brought to our
attention.
Introduction
Throughout the manuscript, reference should have been
made to Bone Marrow Supernatant (BMS) and not Bone
Marrow Aspirate (BMA).
Materials and Methods
Apoptosis assay
Assays using Annexin V and propidium iodide were per-
formed on separate samples (replicates) and not as repeated
measures, a point that was not made clear in the original
article. Separate aliquots of cells for each time point were
kept in culture, without media changes, until assayed.
Cell proliferation assay and Metabolic activity
In alamarBlue® experiments relating to transport media,
we used the interpretation of proliferation because cells
were cultured over several days, allowing time for cell
proliferation to take place. In contrast, when interpreting
viability assays following needle extrusion, we employed
a metabolic activity interpretation because the cells were
cultured for a short period (24 h, Fig. 5) when cell prolif-
eration would not be a prominent feature. Measure-
ments in both instances were of fluorescence.
Results
Figure 3: The Key was accidently omitted. The correct
figure is provided here (Fig. 3).
Figure 5: The y-axis is incorrectly labelled as “Absorb-
ance”. The correct axis label should read “% non-injected
control” and is based on fluorescence readings. The cor-
rect figure is provided here (Fig. 5).
Where appropriate, all figure legends in our article
should state that error bars represent the standard error
of the mean (± SEM).
These corrections do not alter the results or conclusion
of the study that (i) the medium used for transportation of
bone marrow mesenchymal stem cells had a significant
impact on cell viability with increasing transport time and
(ii) the use of a larger needle size (19G) for cell implant-
ation reduced stress-induced loss of viability compared to
smaller needle gauges (21G and 23G).
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Fig. 3 Cell proliferation measured by alamarBlue™ assay for mesenchymal stem cells (MSCs) (n = 3) following storage for 24 or 72 h in suspension
media. a Initial proliferation rates; b Change in the proliferation rate with time following storage for 24 h; c Change in the proliferation rate with
time following storage for 72 h. BMA, bone marrow aspirate; D10, Dulbecco’s Modified Eagle Medium supplemented with 10 % fetal bovine
serum; PRP, platelet rich plasma; HA, hyaluronic acid. Error bars represent the standard error of the mean (± SEM)
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Fig. 5 Analysis of early and late apoptosis and cell metabolic activity after injection through different gauge needles. Data is shown for viability
measured immediately after injection of mesenchymal stem cells (n =3) in D10 through 19G, 20G or 21G needles and in non-injected controls
(NI). a) Annexin V positive cells expressed as a percentage of the total cell population; b propidium iodide-positive cells expressed a percentage
of the total cell population; c metabolic activity (fluorescence) of mesenchymal stem cells measured by alamarBlue™ assay. Error bars represent
the standard error of the mean (± SEM)
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